Picture of Abbvie logo

ABBV Abbvie Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-0.97%
3m+5.06%
6m-3.18%
1yr-12.82%
Volume Change (%)
10d/3m+39.57%
Price vs... (%)
52w High-2.43%
50d MA+3.03%
200d MA+16.86%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)15.62
PEG Ratio (f)0.33
EPS Growth (f)88.65%
Dividend Yield (f)3.49%
Valuation (ttm)IndustryMarket
Price to Book Value30.5
Price to Tang. Bookn/a
Price to Free Cashflow14.32
Price to Sales5.82
EV to EBITDA16.9

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital13.17%
Return on Equity34.91%
Operating Margin23.49%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m33,26645,80456,19758,05454,31854,540.5857,879.0110.65%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-8.27-36.44+99.99+6.38-41.65+146.38+9.04n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Abbvie EPS forecast chart

Profile Summary

AbbVie Inc. is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica, ELAHERE, IMGN-151, Pivekimab Sunirine and Venclexta/Venclyxto; aesthetics products that include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products, which consists of Lumigan/Ganfort, Alphagan/Combigan and Restasis, and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. Its products are sold to wholesalers, distributors, government agencies, health care facilities and more. The Company offers a PINK1 activator which is designed to address mitochondrial dysfunction.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
April 10th, 2012
Public Since
January 2nd, 2013
No. of Shareholders
42,369
No. of Employees
50,000
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
1,770,646,983

ABBV Share Price Performance

Upcoming Events for ABBV

Dividend For ABBV.NLB - 0.2006 CAD

Dividend For ABBV.BA - 0.1550 USD

Dividend For ABBV34.SA - 0.4816 BRL

Dividend For ABBV.NLB - 0.2258 CAD

Dividend For ABBV.N - 1.5500 USD

Q1 2024 AbbVie Inc Earnings Release

AbbVie Inc Annual Shareholders Meeting

AbbVie Inc Annual Shareholders Meeting

Q2 2024 AbbVie Inc Earnings Release

Similar to ABBV

Picture of Bausch Health Companies logo

Bausch Health Companies

us flag iconNew York Stock Exchange

Picture of Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

us flag iconNew York Stock Exchange

Picture of Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

us flag iconNew York Stock Exchange

Picture of Cardinal Health logo

Cardinal Health

us flag iconNew York Stock Exchange

Picture of Catalent logo

Catalent

us flag iconNew York Stock Exchange

FAQ